Zimmer Biomet Holdings Inc.

158.10-0.2400-0.15%Vol 576.60K1Y Perf 20.99%
Jun 16th, 2021 12:47 DELAYED
BID158.08 ASK158.13
Open158.61 Previous Close158.34
Pre-Market- After-Market-
 - -%  - -
Target Price
187.76 
Analyst Rating
Moderate Buy 1.56
Potential %
18.36 
Finscreener Ranking
★+     44.69
Insiders Trans % 3/6/12 mo.
100/100/-33 
Value Ranking
     40.29
Insiders Value % 3/6/12 mo.
100/100/-93 
Growth Ranking
★★+     48.75
Insiders Shares Cnt. % 3/6/12 mo.
100/100/-94 
Income Ranking
+     29.65
Market Cap32.96B 
Earnings Rating
Buy
Price Range Ratio 52W %
67.44 
Earnings Date
3rd Aug 2021

Today's Price Range

156.81159.22

52W Range

112.00180.36

5 Year PE Ratio Range

-52.70175.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.08%
1 Month
-5.34%
3 Months
-1.19%
6 Months
6.38%
1 Year
20.99%
3 Years
39.65%
5 Years
35.94%
10 Years
164.22%

TickerPriceChg.Chg.%
ZBH158.10-0.2400-0.15
AAPL130.240.60000.46
GOOG2 516.58-4.0800-0.16
MSFT258.450.09000.03
XOM64.330.00000.00
WFC44.69-0.7700-1.69
JNJ164.840.35000.21
FB332.19-4.5600-1.35
GE13.48-0.0600-0.44
JPM154.14-1.0400-0.67
Financial StrengthValueIndustryS&P 500US Markets
1.00
2.40
0.38
0.63
3.10
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
69.60
9.40
24.20
5.70
8.25
RevenueValueIndustryS&P 500US Markets
7.09B
34.00
-3.46
0.20
DividendsValueIndustryS&P 500US Markets
0.61
0.96
0.00
0.72
Payout ratio564.00
Earnings HistoryEstimateReportedSurprise %
Q01 20211.511.7113.24
Q04 20202.062.112.43
Q03 20201.051.8172.38
Q02 2020-0.720.05106.94
Q01 20201.391.7022.30
Q04 20192.262.301.77
Q03 20191.761.770.57
Q02 20191.921.930.52
Earnings Per EndEstimateRevision %Trend
6/2021 QR1.843.37Positive
9/2021 QR1.91-4.02Negative
12/2021 FY7.841.95Positive
12/2022 FY8.752.22Positive
Next Report Date3rd Aug 2021
Estimated EPS Next Report1.84
Estimates Count12
EPS Growth Next 5 Years %8.90
Volume Overview
Volume576.60K
Shares Outstanding208.48M
Trades Count7.37K
Dollar Volume309.63M
Avg. Volume1.19M
Avg. Weekly Volume1.03M
Avg. Monthly Volume1.20M
Avg. Quarterly Volume1.05M

Zimmer Biomet Holdings Inc. (NYSE: ZBH) stock closed at 158.34 per share at the end of the most recent trading day (a 0.5% change compared to the prior day closing price) with a volume of 1.38M shares and market capitalization of 32.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 20000 people. Zimmer Biomet Holdings Inc. CEO is Bryan C. Hanson.

The one-year performance of Zimmer Biomet Holdings Inc. stock is 20.99%, while year-to-date (YTD) performance is 2.76%. ZBH stock has a five-year performance of 35.94%. Its 52-week range is between 112 and 180.36, which gives ZBH stock a 52-week price range ratio of 67.44%

Zimmer Biomet Holdings Inc. currently has a PE ratio of 58.20, a price-to-book (PB) ratio of 2.65, a price-to-sale (PS) ratio of 4.63, a price to cashflow ratio of 32.90, a PEG ratio of 2.32, a ROA of 2.22%, a ROC of 3.33% and a ROE of 4.53%. The company’s profit margin is 8.25%, its EBITDA margin is 24.20%, and its revenue ttm is $7.09 Billion , which makes it $34.00 revenue per share.

Of the last four earnings reports from Zimmer Biomet Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.84 for the next earnings report. Zimmer Biomet Holdings Inc.’s next earnings report date is 03rd Aug 2021.

The consensus rating of Wall Street analysts for Zimmer Biomet Holdings Inc. is Moderate Buy (1.56), with a target price of $187.76, which is +18.36% compared to the current price. The earnings rating for Zimmer Biomet Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Zimmer Biomet Holdings Inc. has a dividend yield of 0.61% with a dividend per share of $0.96 and a payout ratio of 564.00%.

Zimmer Biomet Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.50, ATR14 : 2.76, CCI20 : -77.74, Chaikin Money Flow : -0.18, MACD : -2.90, Money Flow Index : 42.27, ROC : -5.54, RSI : 35.09, STOCH (14,3) : 18.32, STOCH RSI : 0.98, UO : 44.75, Williams %R : -81.68), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Zimmer Biomet Holdings Inc. in the last 12-months were: Arthur J. Higgins (Buy at a value of $171 580), Bryan C. Hanson (Option Excercise at a value of $0), Carrie A. Nichol (Option Excercise at a value of $0), Chad F. Phipps (Option Excercise at a value of $1 805 404), Chad F. Phipps (Sold 30 040 shares of value $4 797 388 ), Didier Deltort (Option Excercise at a value of $0), Ivan Tornos (Option Excercise at a value of $0), Rachel Ellingson (Option Excercise at a value of $0), Sang Yi (Option Excercise at a value of $0), Sang Yi (Sold 1 200 shares of value $183 108 ), Suketu Upadhyay (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
19 (70.37 %)
18 (66.67 %)
20 (74.07 %)
Moderate Buy
1 (3.70 %)
1 (3.70 %)
1 (3.70 %)
Hold
7 (25.93 %)
8 (29.63 %)
6 (22.22 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Moderate Buy
1.63
Strong Buy
1.48

Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.

CEO: Bryan C. Hanson

Telephone: +1 574 267-6131

Address: 345 East Main Street, Warsaw 46580, IN, US

Number of employees: 20 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

61%39%

Bearish Bullish

51%49%

News

Stocktwits